Correction: Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs - Report - DentalSpire

Correction: Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs

  • By

  • Jukka H. Meurman

  • Heikki Murtomaa

  • Marja Koski

  • July 9, 2026

Share

Clinical Report: Correction on Oral Discomfort and Health Behaviors in Antipsychotic Patients

Background

Oral health is a critical aspect of overall health, particularly for patients on antipsychotic medications, which can lead to various oral complications. Understanding the impact of these medications on oral health behaviors is essential.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

  • Marja Koski was omitted as an author in the original publication.
  • The article's citation has been updated to include all authors correctly.
  • The copyright statement has been revised to reflect the correct authorship.
  • The In Memoriam statement has been corrected to honor the contributions of the late Heikki Rantanen and Kaija Koski.
  • Author contributions have been updated to include Marja Koski's role in the study.

Clinical Implications

Accurate authorship and acknowledgment in research publications are vital for maintaining the integrity of scientific communication.

Conclusion

This correction serves to clarify authorship and contributions in the study of oral discomfort among patients treated with antipsychotics.

Related Resources & Content

  1. Meurman JH, Murtomaa H and Koski M, Front. Psychiatry, 2024 -- Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs
  2. Bone Marrow Transplantation — Poster Presentations from the Nurses Group at the 47th Annual Conference of the European Society for Blood and Marrow Transplantation (Sessions NP001 – NP028)
  3. Frontiers in Oncology — A randomized controlled trial of telemedicine and e-health interventions for the management of oral complications in oncology patients undergoing antineoplastic therapy
  4. Drugs - Real World Outcomes — Long-Term Continuation of Antipsychotic Therapy in Older Adults with Dementia: A Retrospective Cohort Analysis from a Population Perspective
  5. Drugs - Real World Outcomes — Impact of Disease Progression and Duration of Motor Fluctuations on Opicapone Tolerability: Findings from a Prospective Multicenter Study in Italy on Parkinson’s Disease Management
  6. Absolute neutrophil count and adverse drug reaction monitoring during clozapine treatment: consensus guidelines from a global Delphi panel - ScienceDirect
  7. Oral Adverse Effects of Antipsychotic Medications: A Case/Noncase Analysis of EudraVigilance Data - PubMed
  8. Oral discomfort and health behavior of patients with typical vs. atypical antipsychotic drugs - PMC

Original Source(s)

Related Content